In solid tumors like GBM, IDH1 mutations prevail and confer not only drug resistance but also radioresistance, because of the increased activity of DDR systems and the high activity of de novo and salvage pathways of nucleotide synthesis [65]. This evidence concerns the gene IDH1 and glioblastoma.